Combination of Amphiphilic Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] and Levofloxacin against Multidrug-Resistant Bacteria

Combination of Amphiphilic Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] and Levofloxacin against Multidrug-Resistant Bacteria

Bacterial resistance is a growing global concern necessitating the discovery and development of antibiotics effective against the drug-resistant bacterial strain. Previously, we reported a cyclic antimicrobial peptide [R<sub>4</sub>W<sub>4</sub>] containing arginine (R) and t...

Full description

Bibliographic Details
Main Authors: Muhammad Imran Sajid, Sandeep Lohan, Shun Kato, Rakesh Kumar Tiwari
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Antibiotics
Subjects:
antibacterial resistance
cyclic antimicrobial peptides
checkerboard assay
drug-resistant bacteria
combination therapy
Online Access:https://www.mdpi.com/2079-6382/11/3/416

Internet

https://www.mdpi.com/2079-6382/11/3/416

Similar Items